S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MerusMannKindVanda PharmaceuticalsProvention BioAclaris Therapeutics
SymbolNASDAQ:MRUSNASDAQ:MNKDNASDAQ:VNDANASDAQ:PRVBNASDAQ:ACRS
Price Information
Current Price$22.50$5.71$18.65$12.72$22.28
52 Week RangeBuyBuyHoldBuyN/A
MarketRank™
Overall Score1.41.41.41.40.8
Analysis Score1.33.51.03.50.0
Community Score2.52.22.72.62.6
Dividend Score0.00.00.00.00.0
Ownership Score2.50.81.70.80.8
Earnings & Valuation Score0.60.61.90.00.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyN/A
Consensus Price Target$23.50$7.17$15.40$30.75N/A
% Upside from Price Target4.44% upside25.51% upside-17.43% downside141.75% upsideN/A
Trade Information
Market Cap$711.07 million$1.33 billion$1.02 billion$718.53 million$956.24 million
Beta0.832.280.563.341.2
Average Volume207,0585,275,912606,3191,126,0414,451,205
Sales & Book Value
Annual Revenue$31.13 million$63.04 million$227.19 millionN/A$4.23 million
Price / Sales22.8421.074.51N/A226.06
CashflowN/AN/A$2.88 per shareN/AN/A
Price / CashN/AN/A6.47N/AN/A
Book Value$5.61 per share($0.92) per share$7.70 per share$1.72 per share$1.69 per share
Price / Book4.01-6.212.42N/A13.18
Profitability
Net Income$-55,150,000.00$-51,900,000.00$115.55 million$-43,280,000.00$-161,350,000.00
EPS($2.33)($0.27)$2.11($1.06)($2.25)
Trailing P/E RatioN/AN/A51.81N/AN/A
Forward P/E RatioN/AN/A33.91N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-295.98%-71.92%8.02%N/A-941.07%
Return on Equity (ROE)-78.70%N/A4.56%-67.66%-104.00%
Return on Assets (ROA)-36.12%-46.80%3.88%-62.27%-64.47%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A0.26%
Current Ratio4.43%0.63%6.35%9.23%4.54%
Quick Ratio4.43%0.58%6.33%9.23%4.54%
Ownership Information
Institutional Ownership Percentage62.57%29.60%97.64%39.42%59.10%
Insider Ownership Percentage7.40%1.09%5.90%14.40%8.20%
Miscellaneous
Employees872322841975
Shares Outstanding31.60 million232.60 million54.88 million56.49 million42.92 million
Next Earnings Date3/11/2021 (Estimated)5/5/2021 (Estimated)5/5/2021 (Estimated)5/6/2021 (Estimated)5/6/2021 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.